170406 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving growth factors Fibroblast growth factors [FGF]
Sub-classes:BIOMARKER COMPOSITIONS, PROTEIN PANELS, DEVICES, AND METHODS TO IDENTIFY RISK OF AND TREAT PULMONARY VASCULAR INADEQUACY IN SINGLE VENTRICLE HEART DISEASE
#2METHODS FOR PREDICTING TREATMENT RESPONSE IN PSORIASIS
#3CMYBPC MARKER COMBINATIONS FOR EARLY DISCRIMINATION OF TYPE 2 VERSUS TYPE 1 ACUTE MYOCARDIAL INFARCTION
#4BIOMARKERS AND THEIR USE IN DIAGNOSING PARKINSON'S DISEASE, VITREORETINAL DISEASES, AND AGE-RELATED PATHOLOGIES
#5Systems and Methods for Angiogenic Treatment in Wound Healing
#6Method for Measuring Fibroblast Growth Factor-23 and Reagent Therefor
#7METHODS OF DIAGNOSING AND PREDICTING RENAL DECLINE
#8FGF21 Responsive Reporter Gene Cell Line
#9IMMUNOASSAYS FOR HIGH POSITIVELY CHARGED PROTEINS
#10TYPE 2 CYTOKINES AS PREDICTORS OF DISEASE SEVERITY AND/OR AS THERAPEUTIC TARGETS FOR COVID-19
#11IDENTIFICATION OF PATIENTS WITH ABNORMAL FRACTIONAL SHORTENING
#12PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#13KLOTHO BETA
#14THE FGF19-CHOLESTYRAMINE (F-CME) TEST AS A TWO-STAGE METHOD FOR ROUTINE CANCER SCREENING
#15GENETIC MARKER FOR HELICOBACTER PYLORIASSOCIATED DISEASE
#16BIOMARKERS FOR A THERAPY COMPRISING A SORAFENIB COMPOUND
#17METHODS, KITS AND COMPOSITIONS FOR CHARACTERIZING AN ANTI-INFLAMMATORY RESPONSE OF A PRODUCT
#18Preeclampsia biomarkers and related systems and methods
#19KLOTHO BETA
#20METHODS FOR DETECTING AND QUANTIFYING FGF21
#21SPECIFIC BIOMARKER SET FOR NON-INVASIVE DIAGNOSIS OF LIVER CANCER
#22BIOMARKERS FOR RISK PREDICTION OF MORTALITY
#23COMPOSITIONS AND METHODS FOR FETAL GROWTH
#24PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#25Systems and methods for angiogenic treatment in wound healing
#26Biomarkers of organic acidemias
#27Method for prediction of response to cardiovascular regeneration based on detecting the amount of biomarkers
#28Measurement Method for Fibroblast Growth Factor-23, Measurement Reagent, and Measurement Kit
#29METHODS AND COMPOSITIONS FOR MODULATING FGF23 LEVELS
#30Method for measuring fibroblast growth factor-23 and reagent therefor
#31Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
#32PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#33Method for the early detection of acute kidney injury in critical patients, using fibroblast growth factor 23, klotho and erythropoietin as biomarkers
#34Composition for diagnosing, preventing, or treating vascular smooth muscle cell proliferative diseases using FGF12
#35KLOTHO BETA
#36Assessing whether a subject shall be subjected to imaging based diagnostic
#37Chimeric fibroblast growth factor 21 proteins and methods of use
#38Immune profiling and minimal residue disease following stem cell transplantation in multiple myeloma
#39Diagnosis and treatment of MERS-related renal disease
#40IMMUNOASSAYS FOR HIGH POSITIVELY CHARGED PROTEINS
#41Compositions and methods for diagnosis and treatment of metabolic syndrome
#42Assay for FGF2 Secretion and Signaling
#43Use of fibroblast growth factor 2
#44Specific biomarker set for non-invasive diagnosis of liver cancer
#45Adult stem cells derived from human skin dermis
#46FGF21 protein with enhanced binding affinity for β-Klotho for the treatment of type II diabetes, obesity, and related metabolic disorders
#47Methods useful for vitamin D deficiency and related disorders
#48Chimeric fibroblast growth factor 21 proteins and methods of use
#49Pyrimidine FGFR4 inhibitors
#50Methods for treating cancer by inhibiting FGFR3/TACC3 fusion protein
#51Compositions and methods for diagnosis and treatment of metabolic syndrome
#52Biomarkers for Tuberculosis
#53METHODS AND COMPOSITIONS FOR MODULATING FGF23 LEVELS
#54BIOMARKERS FOR THE DIAGNOSIS AND THE RESPONSE TO TREATMENT OF PANCREATIC CANCER
#55BIOMARKER OF Nrf2 ACTIVATION
#56Methods of treating mesothelioma by administration of compounds comprising FGFR1 ECD
#57NOVEL GROUPS OF BIOMARKERS FOR DIAGNOSING ALZHEIMER'S DISEASE
#58Measurement of FGF21 as a biomarker of fructose metabolism
#59METHODS FOR REGULATING HAIR GROWTH DISORDERS
#60IDENTIFICATION OF PATIENTS WITH ABNORMAL FRACTIONAL SHORTENING
#61Compounds to fibroblast growth factor receptor-3 (FGFR3) and methods of treatment
#62Systems and methods for angiogenic treatment in wound healing
#63Methods For Regulating Hair Growth Disorders
#64Methods for detecting FGFR3/TACC3 fusion genes
#65NON-INVASIVE METHODS FOR ASSESSING OOCYTE QUALITY FOR IN VITRO FERTILIZATION
#66Immunoassays and methods of detecting and measuring intact fibroblast growth factor 23, and C-terminal and N-terminal fragments thereof
#67In vitro assay method using immunological technique
#68Method for measuring fibroblast growth factor-23 and reagent therefor
#69Chimeric FGF21 proteins with enhanced binding affinity for β-klotho for the treatment of type II diabetes, obesity, and related metabolic disorders
#70METHOD OF IN-VITRO IMMUNOASSAY
#71NOVEL BIOMARKERS OF DISEASE HISTOPATHOLOGY
#72Hair Growth-Inhibiting Agent
#73Method for determining the risk of developing brain metastasis, and a kit to carry out said method
#74DYSFUNCTION OF THE MITOCHONDRIAL RESPIRATORY CHAIN, METHODS FOR DIAGNOSIS, TREATMENT AND FOLLOW-UP
#75METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#76NOVEL GROUPS OF BIOMARKERS FOR DIAGNOSING ALZHEIMER'S DISEASE
#77DIAGNOSTIC METHODS AND KITS USING FIBROBLAST GROWTH FACTOR-23
#78Sample hepatocarcinoma classification with YKL-40 to MASP2 concentration ratio
#79Methods useful for vitamin D deficiency and related disorders
#80Methods for treating obesity using fibroblast growth factor-like polypeptides
#81Methods for treating obesity using fibroblast growth factor-like polypeptides
#82Method for screening a test substance for activating a receptor associated with FGF 21 activity
#83HAIR GROWTH-INHIBITING AGENT
#84KLOTHO BETA
#85FGFR4 Promotes Cancer Cell Resistance in Response to Chemotherapeutic Drugs
#86Antibodies to fibroblast growth factor-like polypeptides
#87Antibodies to fibroblast growth factor-like polypeptides
#88Botulinum toxin screening assays
#89Botulinum toxin screening assays
#90Over-expression and mutation of a tyrosine kinase receptor FGFR4 in tumors
#91ROLE OF FGF-19 IN CANCER DIAGNOSIS AND TREATMENT
#92Compounds capable of interacting with a cell-surface fibroblast growth factor receptor
#93Fibroblast growth factor-like polypeptides
#94Therapeutic angiogenesis for treatment of the spine
#95Human FGF-21 gene and gene expression products
#96Methods for treating diabetes using fibroblast growth factor-like polypeptides
#97Methods for treating diabetes using fibroblast growth factor-like polypeptides
#98FGF21 upregulates expression of GLUT-1 in a βklotho-dependent manner
#99Botulinum toxin screening assays
#100Therapeutic agent for hair-related problems and method for screening for the same
#101Method of screening compound preventing cells from infection with Hepatitis C virus (HCV)
#102Fibroblast growth factor-like polypeptides and variants thereof
#103Fibroblast growth factor-like polypeptides and variants thereof
#104Botulinum toxin screening assays
#105Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeutic Intervention
#106Human FGF-21 gene and gene expression products
#107Human FGF-21 gene and gene expression products
#108Metod of modulation of interaction between receptor and ligand
#109Immunoassays, assay methods, antibodies and method of creating antibodies for detecting FGF-23
#110Specific markers for diabetes
#111Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals
#112Human FGF-21 gene and gene expression products
#113Methods for diagnosing and treatment of hyperphosphatemic conditions using FGF20 polypeptides
#114Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders